At a glance: assay reproducibility in oncology

About this Infographic

When protocols are compared, training and accreditation are decisive for reproducibility, pending validation in prospective studies. In routine practice, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, and this trend is expected to continue. In routine practice, threshold harmonization is still an open question, which has direct implications for daily practice. Emerging evidence indicates that real-world registries complement randomized trial evidence, with meaningful differences between subgroups. Recent studies suggest that integrating quantitative measures reduces subjective bias, although confirmatory data are still limited.

In multidisciplinary settings, early intervention correlates with better long-term outcomes, a finding echoed by several independent groups. Longitudinal data show that patient selection criteria deserve closer scrutiny, although confirmatory data are still limited.

In routine practice, variability between operators remains a key limitation, which has direct implications for daily practice. When protocols are compared, pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. Recent studies suggest that threshold harmonization is still an open question, pending validation in prospective studies. In multidisciplinary settings, standardized reporting improves comparability between centers, pending validation in prospective studies. According to consensus recommendations, patient selection criteria deserve closer scrutiny, pending validation in prospective studies.

From a workflow perspective, variability between operators remains a key limitation, as discussed in the accompanying commentary. Emerging evidence indicates that integrating quantitative measures reduces subjective bias, and this trend is expected to continue. In multidisciplinary settings, pre-analytical factors account for a large share of observed variance, pending validation in prospective studies. Longitudinal data show that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, pending validation in prospective studies. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, although confirmatory data are still limited.

When protocols are compared, training and accreditation are decisive for reproducibility, although confirmatory data are still limited. In routine practice, real-world registries complement randomized trial evidence, pending validation in prospective studies. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, as discussed in the accompanying commentary.